Protalix BioTherapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.00
|
|
Average Rating
|
6.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.15
|
-0.07
|
0.08
|
53.33%
|
|
2022-06-30
|
-0.18
|
-0.11
|
0.07
|
38.89%
|
|
2022-03-31
|
-0.04
|
-0.05
|
-0.01
|
-25.00%
|
|
2021-12-31
|
-0.11
|
-0.15
|
-0.04
|
-36.36%
|
|
2021-09-30
|
-0.12
|
-0.09
|
0.03
|
25.00%
|
|
2021-06-30
|
-0.08
|
-0.25
|
-0.17
|
-212.50%
|
|
2021-03-31
|
-0.17
|
-0.14
|
0.03
|
17.65%
|
|
2020-12-31
|
-0.08
|
0.01
|
0.09
|
112.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.23
|
|
2021-12-31
|
-0.63
|
|
2020-12-31
|
-0.16
|
|
2019-12-31
|
-1.18
|
|
2018-12-31
|
-2.77
|
|
2017-12-31
|
-1.23
|
|
2016-12-31
|
-0.40
|
|
2015-12-31
|
0.62
|
|
2014-12-31
|
-1.68
|
|
2013-12-31
|
-3.00
|
|
2012-12-31
|
-1.40
|
|
2011-12-31
|
-4.20
|
|
2010-12-31
|
-3.60
|
|
2009-12-31
|
-4.10
|
|
2008-12-31
|
-3.03
|
|
2007-12-31
|
-3.35
|
|
2006-12-31
|
-2.13
|
|
2005-12-31
|
8.11
|
|
2004-12-31
|
-5.49
|
|
2003-12-31
|
-15.96
|